November 18, 2021
SAN FRANCISCO – (November 18, 2021) – Aizon announces today that the Aizon Bioreactor Application was awarded a Pharma Innovation Award from Pharma Manufacturing. Honored in the Bioprocessing category, the Aizon Bioreactor Application combines artificial intelligence (AI), machine learning (ML), cloud technologies, Internet of Things (IoT) and other data analytics tools in a single Software as a Service (SaaS) platform delivered through the cloud, making it the industry’s first predictive analytics and deep knowledge management application to improve the output of bioreactors in GxP environments.
The continued innovation in the industry achieved through new technology such as Aizon’s Bioreactor Application helps pharmaceutical manufacturers empower data-driven decision making in a way that streamlines production processes, reduces costs, improves yield and helps them keep up with today’s increasingly complex regulatory landscape.
“We work hard every day to help our customers use data science to optimize and standardize their manufacturing processes,” said Toni Manzano, Chief Scientific Officer and co-founder of Aizon. “Getting a better handle on their data allows them to easily generate actionable insights into complex processes in real time that open up a whole slew of use cases and benefits that enable business agility—such as real-time batch monitoring and autonomous manufacturing.” Read rest here.